Validation of the Arabic Version of the Postoperative Quality of Recovery Score 15 (Qor-15Ar)

September 5, 2022 updated by: Younes Aissaoui, MD, Avicenna Military Hospital
Anesthesia practice is not only centered on the patient's safety and well-being through the perioperative period but also on enhancing his overall recovery experience. This study aims to provide an adapted questionnaire for the Arabic-speaking population as a measuring tool of the quality of recovery after surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

With the increasing number of anesthesia procedures performed every year, the concept of rapid rehabilitation after surgery has become a primary goal of the perioperative management of patients. This postoperative recovery concerns not only the physical aspect but also encompasses the general concept of well-being and enhancement of the patient's experience. There are many tools to assess postoperative recovery. However, none has been validated within the Moroccan surgical population.

The Qor-15 (Quality of Recovery) score is a scale for measuring postoperative recovery. It was developed in 2013 by Myles et al and has been validated in a widely variable population [1]. It includes 15 items, each rated from 0 to 10. Our objective is to validate the Arabic version of the QOR-15Ar within a Moroccan surgical population.

Study Type

Observational

Enrollment (Actual)

126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Morocco
    • Marrakesh Tensift El Haouz
      • Marrakesh, Marrakesh Tensift El Haouz, Morocco, 40000
        • Avicenna Military Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients undergoing elective or emergency surgery admitted at Avicenna Military Hospital

Description

Inclusion Criteria:

  • patients admitted for an emergency or elective surgical procedure.

Exclusion Criteria:

  • patients under 18 years old
  • a weak understanding of the Arabic language
  • intracranial Surgery
  • underlying psychiatric pathology compromising the completion of the questionnaire
  • the presence of life-threatening postoperative complications (e.g. hemorrhagic shock, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Crossover
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychometric properties of of the Arabic version of the postoperative quality of recovery score 15 (Qor-15Ar)
Time Frame: Preoperatively and 24 to 48 hours postoperatively.
The psychometric qualities of the Arabic version of the QoR-15Ar include reliability, validity, and sensitivity to change.
Preoperatively and 24 to 48 hours postoperatively.
Acceptability and feasibility of the Arabic version of the postoperative quality of recovery score 15 (Qor-15Ar)
Time Frame: Preoperatively and 24 to 48 hours postoperatively.
The acceptability and feasibility of the questionnaire will be assessed by the participation rate and the time required to complete the questionnaire
Preoperatively and 24 to 48 hours postoperatively.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Avicenna Military Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2022

Primary Completion (Actual)

July 2, 2022

Study Completion (Actual)

July 2, 2022

Study Registration Dates

First Submitted

February 15, 2022

First Submitted That Met QC Criteria

February 15, 2022

First Posted (Actual)

February 17, 2022

Study Record Updates

Last Update Posted (Actual)

September 8, 2022

Last Update Submitted That Met QC Criteria

September 5, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • QoR-15Ar-AMH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The data that support the findings of this study will be available from the investigators upon reasonable request.

IPD Sharing Time Frame

Immediately following the end of the study .

IPD Sharing Access Criteria

Anyone who wish to access the data.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Recovery

Clinical Trials on arabic version of the postoperative Quality of Recovery Score 15

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe